Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Interleukin-12p40 variants with improved stability

Interleukin-12p40 variants with improved stability

US Patent 7872107 · Granted Jan 18, 2011

Estimated economic value: $91,302,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted TGFβ inhibition2022
Anti-CD19 antibodies with reduced immunogenicity2021
SIRP-α immunoglobulin fusion proteins2021
Methods of use of anti-CD19 antibodies with reduced immunogenicity2018
Targeted TGFβ inhibitors2017
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Anti-CD19 antibodies with reduced immunogenicity2015
Antibody fusion proteins with a modified FcRn binding site2014
Antibody fusion proteins with a modified FcRn binding site2014